Informative Censoring in CDK4/6 Inhibitor Adjuvant Therapy for Early Breast Cancer: A Sensitivity Analysis of Invasive Disease-Free Survival in the monarchE Trial. ebph [Internet]. 2025 Sep. 8 [cited 2026 Jul. 27]; Available from: https://test-ojs-unimi-it.archicoop.it/index.php/ebph/article/view/29562